5.38 - 5.60
4.95 - 8.28
2.3K / 2.4K (Avg.)
-279.00 | -0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-2.07%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-2.07%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
88.57%
EBIT growth similar to METSB.HE's 88.57%. Walter Schloss might infer both firms share similar operational efficiencies.
88.57%
Operating income growth similar to METSB.HE's 88.57%. Walter Schloss would assume both share comparable operational structures.
575.00%
Net income growth comparable to METSB.HE's 575.00%. Walter Schloss might see both following similar market or cost trajectories.
500.00%
EPS growth similar to METSB.HE's 500.00%. Walter Schloss would assume both have parallel share structures and profit trends.
500.00%
Similar diluted EPS growth to METSB.HE's 500.00%. Walter Schloss might see standard sector or cyclical influences on both firms.
21.87%
Share count expansion well above METSB.HE's 21.87%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
21.87%
Diluted share count expanding well above METSB.HE's 21.87%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
163.64%
Similar OCF growth to METSB.HE's 163.64%. Walter Schloss would assume comparable operations or industry factors.
46.88%
FCF growth similar to METSB.HE's 46.88%. Walter Schloss would attribute it to parallel capital spending and operational models.
4.37%
Similar 10Y revenue/share CAGR to METSB.HE's 4.37%. Walter Schloss might see both firms benefiting from the same long-term demand.
4.37%
5Y revenue/share CAGR similar to METSB.HE's 4.37%. Walter Schloss might see both companies benefiting from the same mid-term trends.
4.37%
3Y revenue/share CAGR similar to METSB.HE's 4.37%. Walter Schloss would assume both companies experience comparable short-term cycles.
-79.64%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
-79.64%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-79.64%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
148.72%
Similar net income/share CAGR to METSB.HE's 148.72%. Walter Schloss would see parallel tailwinds or expansions for both firms.
148.72%
5Y net income/share CAGR similar to METSB.HE's 148.72%. Walter Schloss might see both on parallel mid-term trajectories.
148.72%
3Y net income/share CAGR similar to METSB.HE's 148.72%. Walter Schloss would attribute it to shared growth factors or demand patterns.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
13.99%
Inventory growth well above METSB.HE's 13.99%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
3.41%
Similar asset growth to METSB.HE's 3.41%. Walter Schloss finds parallel expansions or investment rates.
-13.05%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
1.72%
Debt growth far above METSB.HE's 1.72%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.